Keywords: Bayer, Natazia, FDA approval, Contraceptive, Regorafenib, Colorectal cancer, Onyx, Qlaira

Bayer gains US FDA approval for new combo oral contraceptive Natazia; enrolls Ph III regorafenib study in colorectal cancer

Article | 07 May 2010

Print This

The US Food and Drug Administration yesterday approved Natazia, a novel combination hormonal tablet for use as an oral contraceptive ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in